- Home
- NNN vs CORT Comparison
NNN vs CORT Comparison
Compare NNN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNN
- CORT
- Stock Information
- Founded
- NNN 1984
- CORT 1998
- Country
- NNN United States
- CORT United States
- Employees
- NNN N/A
- CORT N/A
- Industry
- NNN Real Estate Investment Trusts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- NNN Real Estate
- CORT Health Care
- Exchange
- NNN Nasdaq
- CORT Nasdaq
- Market Cap
- NNN 7.8B
- CORT 7.6B
- IPO Year
- NNN N/A
- CORT N/A
- Fundamental
- Price
- NNN $42.58
- CORT $75.18
- Analyst Decision
- NNN Hold
- CORT Strong Buy
- Analyst Count
- NNN 8
- CORT 4
- Target Price
- NNN $44.14
- CORT $139.00
- AVG Volume (30 Days)
- NNN 1.2M
- CORT 675.5K
- Earning Date
- NNN 10-30-2025
- CORT 10-29-2025
- Dividend Yield
- NNN 5.63%
- CORT N/A
- EPS Growth
- NNN N/A
- CORT N/A
- EPS
- NNN 2.10
- CORT 1.11
- Revenue
- NNN $894,702,000.00
- CORT $716,080,000.00
- Revenue This Year
- NNN $5.26
- CORT $30.62
- Revenue Next Year
- NNN $4.00
- CORT $37.68
- P/E Ratio
- NNN $20.30
- CORT $67.23
- Revenue Growth
- NNN 4.82
- CORT 25.71
- 52 Week Low
- NNN $35.80
- CORT $38.68
- 52 Week High
- NNN $49.57
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- NNN 50.69
- CORT 60.68
- Support Level
- NNN $42.36
- CORT $69.03
- Resistance Level
- NNN $43.35
- CORT $74.79
- Average True Range (ATR)
- NNN 0.60
- CORT 2.69
- MACD
- NNN 0.01
- CORT 0.32
- Stochastic Oscillator
- NNN 49.67
- CORT 95.68
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.